Product Information
LATISSE 0.03% EYELASH SOLUTION is a brand product labeled by Allergan, Inc., priced at $31.4314 per ML under NDC 00023361605. Its NADAC has been published 324 times since Aug 22, 2018.
The High Outlier badge above means this manufacturer's average price in the bimatoprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.3 mg/mL
Manufacturer
Allergan, Inc.NDC
00023361605
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BIMATOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA022369On Market Since
1/26/2009
Pharmacological Classes
Price Statistics
The NADAC for LATISSE 0.03% EYELASH SOLUTION has been published 324 times since Aug 22, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.4314 per ML |
|---|---|
| All-time high | $31.6764 (Feb 12, 2020) |
| All-time low | $31.4314 (Jun 17, 2026) |
| 52-week high | $31.5120 |
| 52-week low | $31.4314 |
| Median price | $31.4946 |
| Average price | $31.5368 |
| Largest weekly change | -0.7% (Feb 19, 2020) |
| Weeks tracked | 324 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LATISSE 0.03% EYELASH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LATISSE 0.03% EYELASH SOLUTION, manufactured by Allergan, Inc., is $31.4314 per ML (NDC 00023361605), effective Jun 24, 2026.
How has the price of LATISSE 0.03% EYELASH SOLUTION changed over time?
Over the history we have for it, the NADAC for LATISSE 0.03% EYELASH SOLUTION has held within roughly two percent of its current level. It has been tracked across 324 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for LATISSE 0.03% EYELASH SOLUTION?
Since Aug 22, 2018, the NADAC for LATISSE 0.03% EYELASH SOLUTION has ranged from a low of $31.4314 (Jun 17, 2026) to a high of $31.6764 (Feb 12, 2020), with a median of $31.4946 per ML.
Are there cheaper alternatives to LATISSE 0.03% EYELASH SOLUTION?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BIMATOPROST 0.03% EYELASH SOLN, is $21.9732 per ML — about 30% below LATISSE 0.03% EYELASH SOLUTION.
Who manufactures LATISSE 0.03% EYELASH SOLUTION?
LATISSE 0.03% EYELASH SOLUTION (NDC 00023361605) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification